CA2959869C - Medical apparatus and method - Google Patents
Medical apparatus and method Download PDFInfo
- Publication number
- CA2959869C CA2959869C CA2959869A CA2959869A CA2959869C CA 2959869 C CA2959869 C CA 2959869C CA 2959869 A CA2959869 A CA 2959869A CA 2959869 A CA2959869 A CA 2959869A CA 2959869 C CA2959869 C CA 2959869C
- Authority
- CA
- Canada
- Prior art keywords
- luminous intensity
- light
- medical apparatus
- ratio
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 17
- 230000005855 radiation Effects 0.000 claims abstract description 32
- 230000005670 electromagnetic radiation Effects 0.000 claims abstract description 19
- 230000001815 facial effect Effects 0.000 claims description 8
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims description 7
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 7
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- 230000003287 optical effect Effects 0.000 claims description 5
- 230000014509 gene expression Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 210000004204 blood vessel Anatomy 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 11
- 210000001525 retina Anatomy 0.000 description 11
- 206010012689 Diabetic retinopathy Diseases 0.000 description 10
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Chemical compound [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
- 230000004438 eyesight Effects 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 208000000208 Wet Macular Degeneration Diseases 0.000 description 7
- 238000000151 deposition Methods 0.000 description 7
- -1 poly(3,4-ethylenedioxythiophene) Polymers 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 230000004300 dark adaptation Effects 0.000 description 5
- 230000036284 oxygen consumption Effects 0.000 description 5
- 206010025421 Macule Diseases 0.000 description 4
- 229920001609 Poly(3,4-ethylenedioxythiophene) Polymers 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 206010012688 Diabetic retinal oedema Diseases 0.000 description 3
- 229910002601 GaN Inorganic materials 0.000 description 3
- 229920000144 PEDOT:PSS Polymers 0.000 description 3
- 206010064930 age-related macular degeneration Diseases 0.000 description 3
- 238000000295 emission spectrum Methods 0.000 description 3
- 208000002780 macular degeneration Diseases 0.000 description 3
- 239000002858 neurotransmitter agent Substances 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- ICPSWZFVWAPUKF-UHFFFAOYSA-N 1,1'-spirobi[fluorene] Chemical compound C1=CC=C2C=C3C4(C=5C(C6=CC=CC=C6C=5)=CC=C4)C=CC=C3C2=C1 ICPSWZFVWAPUKF-UHFFFAOYSA-N 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 238000007646 gravure printing Methods 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 210000000608 photoreceptor cell Anatomy 0.000 description 2
- 108091008695 photoreceptors Proteins 0.000 description 2
- 238000001126 phototherapy Methods 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- 208000012672 seasonal affective disease Diseases 0.000 description 2
- 238000007764 slot die coating Methods 0.000 description 2
- 238000004528 spin coating Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000002207 thermal evaporation Methods 0.000 description 2
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- GEQBRULPNIVQPP-UHFFFAOYSA-N 2-[3,5-bis(1-phenylbenzimidazol-2-yl)phenyl]-1-phenylbenzimidazole Chemical compound C1=CC=CC=C1N1C2=CC=CC=C2N=C1C1=CC(C=2N(C3=CC=CC=C3N=2)C=2C=CC=CC=2)=CC(C=2N(C3=CC=CC=C3N=2)C=2C=CC=CC=2)=C1 GEQBRULPNIVQPP-UHFFFAOYSA-N 0.000 description 1
- VQGHOUODWALEFC-UHFFFAOYSA-N 2-phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=CC=N1 VQGHOUODWALEFC-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- JMASRVWKEDWRBT-UHFFFAOYSA-N Gallium nitride Chemical compound [Ga]#N JMASRVWKEDWRBT-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 206010038933 Retinopathy of prematurity Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 201000007917 background diabetic retinopathy Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004155 blood-retinal barrier Anatomy 0.000 description 1
- 230000004378 blood-retinal barrier Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical group 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000011190 diabetic macular edema Diseases 0.000 description 1
- 208000011325 dry age related macular degeneration Diseases 0.000 description 1
- 238000000407 epitaxy Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002102 hyperpolarization Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- MILUBEOXRNEUHS-UHFFFAOYSA-N iridium(3+) Chemical compound [Ir+3] MILUBEOXRNEUHS-UHFFFAOYSA-N 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000018769 loss of vision Diseases 0.000 description 1
- 231100000864 loss of vision Toxicity 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 210000003668 pericyte Anatomy 0.000 description 1
- 230000004310 photopic vision Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000004439 pupillary reactions Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 210000003994 retinal ganglion cell Anatomy 0.000 description 1
- 210000001210 retinal vessel Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000004296 scotopic vision Effects 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 239000000126 substance Chemical group 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000004862 vasculogenesis Effects 0.000 description 1
- 230000007998 vessel formation Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0622—Optical stimulation for exciting neural tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
- A61N2005/0627—Dose monitoring systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
- A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
- A61N2005/0648—Applicators worn by the patient the applicator adapted to be worn on the head the light being directed to the eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
- A61N2005/0652—Arrays of diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
- A61N2005/0653—Organic light emitting diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0656—Chemical light sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0664—Details
- A61N2005/0667—Filters
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiation-Therapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1315836.5 | 2013-09-05 | ||
| GBGB1315836.5A GB201315836D0 (en) | 2013-09-05 | 2013-09-05 | Medical apparatus and method |
| PCT/GB2014/052627 WO2015033114A1 (en) | 2013-09-05 | 2014-08-29 | Medical apparatus and method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2959869A1 CA2959869A1 (en) | 2015-03-12 |
| CA2959869C true CA2959869C (en) | 2021-12-28 |
Family
ID=49486795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2959869A Active CA2959869C (en) | 2013-09-05 | 2014-08-29 | Medical apparatus and method |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US10888709B2 (enExample) |
| EP (1) | EP3041575B1 (enExample) |
| JP (1) | JP6473754B2 (enExample) |
| KR (1) | KR102508596B1 (enExample) |
| CN (1) | CN105682737B (enExample) |
| AU (1) | AU2014316860B2 (enExample) |
| BR (1) | BR112016004943B1 (enExample) |
| CA (1) | CA2959869C (enExample) |
| DK (1) | DK3041575T3 (enExample) |
| ES (1) | ES2694111T3 (enExample) |
| GB (1) | GB201315836D0 (enExample) |
| MX (1) | MX360241B (enExample) |
| PL (1) | PL3041575T3 (enExample) |
| PT (1) | PT3041575T (enExample) |
| SG (1) | SG11201601684PA (enExample) |
| SI (1) | SI3041575T1 (enExample) |
| TR (1) | TR201816306T4 (enExample) |
| TW (1) | TWI673081B (enExample) |
| WO (1) | WO2015033114A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201315836D0 (en) * | 2013-09-05 | 2013-10-23 | Polyphotonix Ltd | Medical apparatus and method |
| US10512534B2 (en) | 2016-10-03 | 2019-12-24 | California Institute Of Technology | Radioluminescent phototherapy eye device |
| WO2019152526A1 (en) | 2018-01-31 | 2019-08-08 | California Institute Of Technology | Controllable ocular phototherapy |
| EP3542857A1 (en) * | 2018-03-19 | 2019-09-25 | Rucker, Frances Joan | Balanced cone excitation for controlling refractive error and ocular growth to inhibit development of myopia |
| CA3118281C (en) * | 2018-10-30 | 2022-06-14 | Multi Radiance Medical | Photobiomodulation therapy to treat a degenerative condition of the retina and/or the optic nerve |
| US11666485B2 (en) * | 2019-03-01 | 2023-06-06 | LumosTech, Inc. | Adjustable mask |
| CN114870275A (zh) * | 2022-05-24 | 2022-08-09 | 深圳市雏鹰视界健康科技有限公司 | 一种眼部智能生物视光仪和眼睛训练方法 |
| CN120000146B (zh) * | 2024-09-27 | 2025-10-17 | 中国人民解放军空军军医大学 | 一种快速中间视觉暗适应功能检查方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3044184A1 (de) * | 1980-11-24 | 1982-06-16 | Mutzhas Maximilian F | Vorrichtung zur phototherapeutischen behandlung der hyperbilirubinaemie |
| US5015924A (en) * | 1989-04-14 | 1991-05-14 | The United States Of America As Represented By The United States Department Of Energy | Pupillary efficient lighting system |
| US7678140B2 (en) | 2000-05-10 | 2010-03-16 | George Brainard | Photoreceptor system for melatonin regulation and phototherapy |
| US7015636B2 (en) * | 2002-10-23 | 2006-03-21 | Charles Bolta | Balanced blue spectrum therapy lighting |
| US20040225340A1 (en) * | 2003-03-10 | 2004-11-11 | Evans James W. | Light/breath/meditation device |
| JP4630864B2 (ja) | 2003-05-01 | 2011-02-09 | フリンダーズ パートナーズ ピーティワイ リミテッド | 光刺激を与えるための装置 |
| US20050278003A1 (en) * | 2004-05-12 | 2005-12-15 | Harold Feldman | Electroluminescent light therapy devices |
| US20100081185A1 (en) | 2004-08-17 | 2010-04-01 | Mcdaniel David H | System and method for photodynamic cell therapy |
| JP2008237618A (ja) * | 2007-03-27 | 2008-10-09 | Toin Gakuen | 光力学的治療用光照射装置 |
| KR20100027186A (ko) | 2007-05-31 | 2010-03-10 | 코닌클리즈케 필립스 일렉트로닉스 엔.브이. | 조명 및 생리적 자극 제공 방법 및 시스템 |
| ATE535754T1 (de) * | 2007-07-26 | 2011-12-15 | Innolumis Public Lighting B V | STRAßENBELEUCHTUNGSANORDNUNG |
| JP2010162214A (ja) * | 2009-01-16 | 2010-07-29 | Kagoshima Univ | 光照射装置 |
| CA2756668A1 (en) * | 2009-03-25 | 2010-09-30 | High Performance Optics, Inc. | Photochromic ophthalmic systems that selectively filter specific blue light wavelengths |
| JP5808318B2 (ja) * | 2009-04-24 | 2015-11-10 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 被験者の眼球に電磁放射を送達するシステム |
| GB201007256D0 (en) | 2010-04-30 | 2010-06-16 | Polyphotonix Ltd | Radiation treatment apparatus |
| CN102905750B (zh) * | 2010-05-14 | 2016-04-06 | 皇家飞利浦电子股份有限公司 | 用于使用两个或更多波长段的电磁辐射给受试者提供光疗的系统 |
| JP5993844B2 (ja) | 2010-05-14 | 2016-09-14 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 睡眠マスクを用いる効率的な概日系及び間連する系の調節 |
| EP2422844A1 (en) | 2010-08-24 | 2012-02-29 | Polyphotonix Limited | Wearable phototherapy device |
| EP2422845B1 (en) | 2010-08-24 | 2013-04-24 | Polyphotonix Limited | Lightguide phototherapy apparatus |
| GB201104369D0 (en) | 2011-03-15 | 2011-04-27 | English Stuart G | Light treatment cartridge |
| WO2012174245A1 (en) * | 2011-06-14 | 2012-12-20 | Children's Hospital Medical Center | Devices and treatment methods for vascular eye di |
| US9278029B2 (en) | 2011-10-19 | 2016-03-08 | Iridex Corporation | Short duration pulse grid pattern laser treatment and methods |
| US20140257439A1 (en) * | 2013-03-06 | 2014-09-11 | Verilux, Inc. | Adjustable therapeutic lights |
| GB201315836D0 (en) * | 2013-09-05 | 2013-10-23 | Polyphotonix Ltd | Medical apparatus and method |
-
2013
- 2013-09-05 GB GBGB1315836.5A patent/GB201315836D0/en not_active Ceased
-
2014
- 2014-08-29 BR BR112016004943-8A patent/BR112016004943B1/pt active IP Right Grant
- 2014-08-29 CN CN201480060273.3A patent/CN105682737B/zh active Active
- 2014-08-29 SI SI201430938T patent/SI3041575T1/sl unknown
- 2014-08-29 PL PL14758632T patent/PL3041575T3/pl unknown
- 2014-08-29 ES ES14758632.5T patent/ES2694111T3/es active Active
- 2014-08-29 US US14/916,863 patent/US10888709B2/en active Active
- 2014-08-29 AU AU2014316860A patent/AU2014316860B2/en active Active
- 2014-08-29 MX MX2016002874A patent/MX360241B/es active IP Right Grant
- 2014-08-29 SG SG11201601684PA patent/SG11201601684PA/en unknown
- 2014-08-29 TR TR2018/16306T patent/TR201816306T4/tr unknown
- 2014-08-29 PT PT14758632T patent/PT3041575T/pt unknown
- 2014-08-29 DK DK14758632.5T patent/DK3041575T3/en active
- 2014-08-29 CA CA2959869A patent/CA2959869C/en active Active
- 2014-08-29 WO PCT/GB2014/052627 patent/WO2015033114A1/en not_active Ceased
- 2014-08-29 KR KR1020167009030A patent/KR102508596B1/ko active Active
- 2014-08-29 EP EP14758632.5A patent/EP3041575B1/en active Active
- 2014-08-29 JP JP2016539631A patent/JP6473754B2/ja active Active
- 2014-09-02 TW TW103130235A patent/TWI673081B/zh active
-
2020
- 2020-07-13 US US16/927,072 patent/US11654296B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX360241B (es) | 2018-10-26 |
| CN105682737B (zh) | 2018-05-08 |
| BR112016004943A2 (pt) | 2017-08-01 |
| DK3041575T3 (en) | 2018-11-26 |
| US10888709B2 (en) | 2021-01-12 |
| PL3041575T3 (pl) | 2019-03-29 |
| SI3041575T1 (sl) | 2018-12-31 |
| JP6473754B2 (ja) | 2019-02-20 |
| CA2959869A1 (en) | 2015-03-12 |
| TWI673081B (zh) | 2019-10-01 |
| ES2694111T3 (es) | 2018-12-18 |
| CN105682737A (zh) | 2016-06-15 |
| AU2014316860A1 (en) | 2016-04-28 |
| KR20160064126A (ko) | 2016-06-07 |
| US11654296B2 (en) | 2023-05-23 |
| US20200346031A1 (en) | 2020-11-05 |
| US20160220841A1 (en) | 2016-08-04 |
| TW201513911A (zh) | 2015-04-16 |
| GB201315836D0 (en) | 2013-10-23 |
| KR102508596B1 (ko) | 2023-03-10 |
| MX2016002874A (es) | 2016-06-22 |
| EP3041575A1 (en) | 2016-07-13 |
| EP3041575B1 (en) | 2018-08-08 |
| TR201816306T4 (tr) | 2018-11-21 |
| WO2015033114A1 (en) | 2015-03-12 |
| AU2014316860B2 (en) | 2019-05-16 |
| BR112016004943B1 (pt) | 2021-08-17 |
| SG11201601684PA (en) | 2016-04-28 |
| PT3041575T (pt) | 2018-11-20 |
| JP2016529056A (ja) | 2016-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11654296B2 (en) | Medical apparatus and method | |
| US20100179469A1 (en) | Organic Light Emitting Diode Phototherapy Lighting System | |
| JP2012514498A5 (enExample) | ||
| EP2810315A1 (en) | Nanocrystals on fibers | |
| WO2012110178A1 (en) | Device and method for treatment of cells and cell tissue | |
| US20220233878A1 (en) | Light source for eye therapy and light emitting device having the same | |
| JP2022115968A (ja) | 運動関連の神経疾患を患っている患者に光治療を施すための装置及びシステム | |
| US20210001145A1 (en) | Controlling myopia in humans | |
| JP6129959B2 (ja) | 筋肉運動関連の神経疾患を患っている患者に使用するためのシステム | |
| US12377286B2 (en) | Anti-infective and therapeutic electromagnetic emission methods and devices | |
| WO2024227057A2 (en) | Light emitting opthalmic lens | |
| US20250360336A1 (en) | Anti-infective and therapeutic electromagnetic emission methods and devices | |
| US20250144444A1 (en) | Organic light-emitting short-term visual stimulation platform for brain function control | |
| US20230364441A1 (en) | Device and method for inhibiting choroidal thinning | |
| HK1210976B (zh) | 一种用於患有与运动相关的神经疾病的对象的系统 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20190819 |